Industries > Pharma > Global Pharma Contract Sales Market 2019-2029

Global Pharma Contract Sales Market 2019-2029

Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services, Cardiovascular Disease, Metabolic Disorders, Oncology

PUBLISHED: 28 February 2019
PAGES: 253
PRODUCT CODE: PHA0357
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0357 Categories: , Tag:

The global pharma contract sales market is expected to grow at a CAGR of 8.9% in the first half of the forecast period. In 2018, the contract detailing segment held 76% of the global pharma contract sales market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 253-page report you will receive 104 tables and 67 figures– all unavailable elsewhere.

The 253-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharma Contract Sales Market forecasts from 2019-2029

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2029 for the following submarket by leading services:
• Contract detailing (personal promotion/field sales)
• Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
• Medical education services
• Sample management services

• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
• Cardiovascular disease
• Metabolic disorders
• Oncology
• Other

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• US
• Japan
• EU5: Germany, UK, France, Italy and Spain
• BRIC: China, India, Brazil and Russia

The US, Japan, EU5 and BRIC markets are further segmented by therapeutic segments and leading services

Global Pharma Contract Sales Market 2019-2029

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study also discusses factors that will drive and restrain the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market:
• Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
Services CSOs offer and benefits to drug companies outsourcing medical sales
• Maturing brands and product launches, including flexibility in field sales teams
Legislation and new market access requirements for pharma sales representatives
• Changes to online marketing and potential for IT technologies Risk-sharing agreements
Key account management (KAM) and medical science liaison (MSL)

• This report discusses the leading companies in pharma contract sales:
• CMIC
• IQVIA
• Marvecs
• OnCall, LLC
• Publicis Healthcare Communications Group (PHCG)
• Sofip
• Syneos Health (INC Research and inVentiv Health
• UDG Healthcare

Visiongain’s study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions.

Buy our report today Global Pharma Contract Sales Market 2019-2029: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services, Cardiovascular Disease, Metabolic Disorders, Oncology.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2019-2029


Latest Pharma news

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2022-2032

The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.

13 September 2022

READ